At its February meeting, EMA's
https://nitter.cz/search?q=%23safety
committee reminded healthcare professionals of the risk of serious adverse reactions with the COVID-19 therapeutic Paxlovid, when taken together with certain immunosuppressants.
👉
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-february-2024
https://nitter.cz/search?q=%23SafetyOfMedicines
https://nitter.cz/search?q=%23PRAC

🐦🔗: https://nitter.cz/EMA_News/status/1755929090509426959#m

[2024-02-09 12:18 UTC]